ACC.26 advanced registration ends Feb. 12 – register now!

Anna D. Narezkina, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Pharmacyclics, LLC(MODEST), Janssen Scientific Affairs, LLC(SIGNIFICANT), Abbott Laboratories(MODEST)

View Full Disclosure